Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Apr 16, 2018 · 10-Q · 47 days after period end · 0001640334-18-000736
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$798.46K | -$13.01K | -$5.09K | -$6.15K |
| EPS Diluted | -$0.07 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Feb 28, 2018 · filed Apr 16, 2018 · 47 d after period end
